Sheila F. Faraj

<i>TERT</i> Promoter Mutations Occur Early in Urothelial Neoplasia and Are Biomarkers of Early Disease and Disease Recurrence in Urine

Isaac Kinde, Enrico Munari, Sheila F. Faraj et al. · Cancer Research · 2013 · 248 citations · Full text

Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk Men

Ashley E. Ross, Michael H. Johnson, Kasra Yousefi et al. · European Urology · 2015 · 243 citations

Urology, High-risk Men, Biostatistics +5

Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial

Jean Felipe Prodocimo Lestingi, Giuliano Guglielmetti, Quoc‐Dien Trinh et al. · European Urology · 2020 · 228 citations

Urology, Surgical Oncology, High-risk Prostate Cancer +7

¹⁸F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer

Steven P. Rowe, Kenneth L. Gage, Sheila F. Faraj et al. · Journal of Nuclear Medicine · 2015 · 195 citations · Full text

Assessment of Tumoral PD-L1 Expression and Intratumoral CD8+ T Cells in Urothelial Carcinoma

Sheila F. Faraj, Enrico Munari, Güneş Güner et al. · Urology · 2015 · 181 citations

Urology, Cancer Immunosurveillance, Genitourinary Cancer +8